Skip to main content
Top
Published in: Critical Care 5/2003

01-10-2003 | Commentary

Recent progress in sepsis epidemiology – have we learned enough?

Authors: Herwig Gerlach, Didier Keh

Published in: Critical Care | Issue 5/2003

Login to get access

Abstract

The encouraging results of recent clinical trials on therapy of severe sepsis and septic shock are paralleled by ongoing studies on the epidemiology of sepsis and infection in intensive care unit patients all over the world. The development of network-based systems for assessing morbidity and mortality in intensive care unit patients has contributed to a significant improvement in quality of care. Data from the SOAP (Sepsis Occurrence in the Acutely Ill Patient) study demonstrate that the treatment of septic patients varies widely, and that even those strategies that have been evaluated are not yet implemented in routine practice. Hence, activities on surveillance and education still merit further attention.
Literature
1.
go back to reference Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001, 344: 699-709. 10.1056/NEJM200103083441001.CrossRefPubMed Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001, 344: 699-709. 10.1056/NEJM200103083441001.CrossRefPubMed
2.
go back to reference Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001, 345: 1368-1377. 10.1056/NEJMoa010307.CrossRefPubMed Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001, 345: 1368-1377. 10.1056/NEJMoa010307.CrossRefPubMed
3.
go back to reference Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaut P, Bellissant E: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002, 288: 862-871. 10.1001/jama.288.7.862.CrossRefPubMed Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaut P, Bellissant E: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002, 288: 862-871. 10.1001/jama.288.7.862.CrossRefPubMed
4.
go back to reference Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002.CrossRefPubMed Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002.CrossRefPubMed
5.
go back to reference Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulme R, Lepage E, Le Gall R: Epidemiology of sepsis and infection in ICU patients from an international multicenter cohort study. Intensive Care Med. 2002, 28: 108-121. 10.1007/s00134-001-1143-z.CrossRefPubMed Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulme R, Lepage E, Le Gall R: Epidemiology of sepsis and infection in ICU patients from an international multicenter cohort study. Intensive Care Med. 2002, 28: 108-121. 10.1007/s00134-001-1143-z.CrossRefPubMed
6.
go back to reference Vincent JL, Sakr Y, Carlet J, Gerlach H, Le Gall JR, Moreno R, Payen D, Ranieri M, Reinhart K, Charles Sprung, on behalf of the SOAP investigators: Sepsis Occurrence in Acutely ill Patients (SOAP): results of a large European multicentric study [abstract]. Abstract presented at the 32nd Critical Care Congress of the Society of Critical Care Medicine, San Antonio, USA. 2003 Vincent JL, Sakr Y, Carlet J, Gerlach H, Le Gall JR, Moreno R, Payen D, Ranieri M, Reinhart K, Charles Sprung, on behalf of the SOAP investigators: Sepsis Occurrence in Acutely ill Patients (SOAP): results of a large European multicentric study [abstract]. Abstract presented at the 32nd Critical Care Congress of the Society of Critical Care Medicine, San Antonio, USA. 2003
7.
go back to reference The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000, 342: 1301-1308. 10.1056/NEJM200005043421801.CrossRef The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000, 342: 1301-1308. 10.1056/NEJM200005043421801.CrossRef
8.
9.
go back to reference Cheon-Lee E, Amstey MS: Compliance with the Centers for Disease Control and prevention antenatal culture protocol for preventing group B streptococcal neonatal sepsis. Am J Obstet Gynecol. 1998, 179: 77-79.CrossRefPubMed Cheon-Lee E, Amstey MS: Compliance with the Centers for Disease Control and prevention antenatal culture protocol for preventing group B streptococcal neonatal sepsis. Am J Obstet Gynecol. 1998, 179: 77-79.CrossRefPubMed
10.
go back to reference Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med. 2003, 348: 138-150. 10.1056/NEJMra021333.CrossRefPubMed Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med. 2003, 348: 138-150. 10.1056/NEJMra021333.CrossRefPubMed
11.
go back to reference Sessler CN, Shephard W: New concepts in sepsis. Curr Opin Crit Care. 2002, 8: 465-472. 10.1097/00075198-200210000-00016.CrossRefPubMed Sessler CN, Shephard W: New concepts in sepsis. Curr Opin Crit Care. 2002, 8: 465-472. 10.1097/00075198-200210000-00016.CrossRefPubMed
12.
go back to reference Brun-Buisson C: The epidemiology of the systemic inflammatory response. Intensive Care Med. 2000, 26 (suppl 1): S64-S74. 10.1007/s001340051121.CrossRefPubMed Brun-Buisson C: The epidemiology of the systemic inflammatory response. Intensive Care Med. 2000, 26 (suppl 1): S64-S74. 10.1007/s001340051121.CrossRefPubMed
13.
go back to reference Coughlin MT, Angus DC: Economic evaluation of new therapies in critical illness. Crit Care. 2003, 31 (suppl): S7-S16.CrossRef Coughlin MT, Angus DC: Economic evaluation of new therapies in critical illness. Crit Care. 2003, 31 (suppl): S7-S16.CrossRef
Metadata
Title
Recent progress in sepsis epidemiology – have we learned enough?
Authors
Herwig Gerlach
Didier Keh
Publication date
01-10-2003
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2003
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc2175

Other articles of this Issue 5/2003

Critical Care 5/2003 Go to the issue